Shares of Viking Therapeutics (VKTX) are rising after data from the company's latest weight loss drug trial showed greater efficacy compared to competing products from Eli Lilly and Company (LLY) and Novo Nordisk A/S (NVO). On Tuesday, the company also announced that it initiated an underwritten…
#elilillyandcompany #lly #novonordiskas #yahoofinancehealth #anjaleekhemlani #yahoofinancelive #nicholasjacobino #glp1 #vikingtherapeutics #lilly
Continue reading...